Skip to main content

MoneyWorks4Me

Lupin informs about press release

07 Oct 2022 Evaluate
Lupin has informed that it enclosed a Press Release as regards, appointment of Shahin Fesharaki as Global Chief Scientific Officer of the Company. This is a disclosure pursuant to Regulation 30 of the Listing Regulations.

The above information is a part of company’s filings submitted to BSE

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..